Medicines Co. shares fall after FDA panel rejects drug application 11:54 a.m. Feb. 13, 2014 - Russ Britt
FDA reviewing Medicines Co. anti-clotting drug 8:56 a.m. Feb. 12, 2014 - MarketWatch.com
Three biopharma companies poised for product OKs in 2014: analyst 1:51 p.m. Jan. 6, 2014 - Russ Britt
Sam Eisenstadt still bullish on stocks 4:28 p.m. Dec. 27, 2013 - Mark Hulbert
Why I stopped using stop loss orders 8:31 a.m. May 9, 2013 - Michael Sincere
Dow, Nasdaq challenge multiyear highs 1:43 p.m. Feb. 19, 2013 - Michael Ashbaugh
Dow, Nasdaq rattle cage on multi-year highs 12:31 p.m. Feb. 19, 2013 - Michael Ashbaugh
Updates, advisories and surprises 10:01 p.m. July 25, 2012 - MarketWatch
Medicines Co. shares jump 12% on earnings report 12:17 p.m. July 25, 2012 - Val Brickates Kennedy
Corrective bounce, or sustainable upturn? 10:59 a.m. June 6, 2012 - Michael Ashbaugh
Stocks to watch Wednesday: Prestige, Timken, Dell 7:59 a.m. Feb. 22, 2012 - MarketWatch
Friday's biggest gaining and declining stocks 5:25 p.m. Sept. 10, 2010 - MarketWatch
Medicines Co. says patent extension denied 6:29 p.m. March 19, 2010 - Wallace Witkowski
Medicines Co. shares tumble on patent defeat 3:50 p.m. March 19, 2010 - Val Brickates Kennedy
A.P. Pharma, Medicines Co. sink 12:22 p.m. March 19, 2010 - Val Brickates Kennedy
Medicines Co. shares reverse, down 9.7% to $8.40 12:01 p.m. March 19, 2010 - Wallace Witkowski
Wednesday's biggest gaining and declining stocks 5:08 p.m. March 17, 2010 - MarketWatch
Abraxis soars; Molecular Insight falls 1:14 p.m. March 17, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 5:27 p.m. Feb. 17, 2010 - MarketWatch
Medicines Co. gets wider EU OK for anticoagulant 5:03 a.m. Dec. 1, 2009 - Robert Daniel
As Antibiotics Stop Working, Five Biotechs Seek Cures 8:13 a.m. June 20, 2014 - 247WallSt.com
Top Swing Trade Ideas for Wednesday June 11: Facebook, Vivus, More 9:37 a.m. June 11, 2014 - TheStreet.com
Phase 3 results for oritavancin 7:32 a.m. June 5, 2014 - Seeking Alpha
The Medicines Company (MDCO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. May 30, 2014 - Zacks.com
Long Swing Picks After the Memorial Day Weekend: Isis, Tibco, More 11:12 a.m. May 27, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – SRPT ISIS MDCO NPSP 8:30 a.m. May 23, 2014 - InvestorPlace.com
10-Q: MEDICINES CO /DE 2:43 p.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Antibiotics Approvals to Surge 7:06 a.m. May 12, 2014 - Barrons.com
CRL for The Medicines Co.'s Cangrelor - Analyst Blog 4:05 p.m. May 1, 2014 - Zacks.com
Medicines Company gets a CRL on antiplatelet drug 10:35 a.m. May 1, 2014 - Seeking Alpha
Biotech Stock Roundup: Gilead's Sovaldi Shines, Biogen & Alexion Up Outlook - Analyst Blog 10:55 a.m. April 30, 2014 - Zacks.com
The Medicines Co.'s Q1 Earnings Surpass Expectations - Analyst Blog 11:40 a.m. April 24, 2014 - Zacks.com
The Medicines Company's CEO Discusses Q1 2014 Results - Earnings Call Transcript 1:00 p.m. April 23, 2014 - Seeking Alpha
Notable earnings before Wednesday’s open 12:05 a.m. April 23, 2014 - Seeking Alpha
Notable earnings before Wednesday’s open 5:30 p.m. April 22, 2014 - Seeking Alpha
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog 10:07 a.m. April 16, 2014 - Zacks.com
Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst Blog 12:46 p.m. April 9, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – WCG MDCO PCRX CNC 1:15 p.m. April 8, 2014 - InvestorPlace.com
The Medicines Co's Fibrocaps Under U.S. Review - Analyst Blog 6:08 p.m. April 4, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – ISRG QCOR NVDQ MDCO 7:15 a.m. April 3, 2014 - InvestorPlace.com
Health Care Sector Equities Coverage -- Research on Johnson and Johnson, Medicines Co., Merck, and Novo Nordisk 7:40 a.m. June 13, 2014 - PR Newswire - PRF
Dosing Initiation, Conferences Participation, Trial Results Publication, and Financial Results - Analyst Notes on Arena, Acceleron Pharma, HealthSouth, The Medicines Company and Taro 5:40 a.m. June 10, 2014 - PR Newswire - PRF
ORBACTIVTM (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine 6:01 a.m. June 5, 2014 - BusinessWire - BZX
The Medicines Company to Participate in Goldman Sachs 35th Annual Global Healthcare Conference 4:21 p.m. June 4, 2014 - BusinessWire - BZX
Critical Alerts For Microsoft, Medicines, LinkedIn, Priceline, and Qihoo 360 Technology Released By InvestorsObserver 9:31 a.m. May 29, 2014 - PR Newswire - PRF
The Medicines Company to Participate in 2014 Jefferies Global Healthcare Conference 3:54 p.m. May 27, 2014 - BusinessWire - BZX
Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal 7:01 a.m. May 22, 2014 - BusinessWire - BZX
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 7:20 a.m. May 16, 2014 - PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn 11:30 a.m. May 9, 2014 - PR Newswire - PRF
The Medicines Company to Host Surgery and Perioperative Care Investor and Analyst Meeting on May 22 12:09 p.m. May 8, 2014 - BusinessWire - BZX
The Medicines Company to Participate in 2014 Bank of America Global Healthcare Conference 1:58 p.m. May 6, 2014 - BusinessWire - BZX
The Medicines Company and Alnylam Announce Presentation of New Pre-Clinical Data on PCSK9 at Arteriosclerosis, Thrombosis and Vascular Biology 2014 Scientific Sessions 11:02 a.m. May 1, 2014 - Marketwire
The Medicines Company Receives Complete Response Letter From FDA Requesting Additional Information for New Drug Application for Its Antiplatelet Agent Cangrelor 7:44 p.m. April 30, 2014 - Marketwire
Generic Drugs Industry Announces Earnings Results, Leadership Appointments, and Conference Participation - Analyst Notes on Mylan, Zoetis, Hospira, Horizon Pharma and The Medicines Co 8:00 a.m. April 30, 2014 - PR Newswire - PRF
Critical Alerts For American Express, Time Warner, Nasdaq OMX Group, The Medicines Company, and PetSmart By InvestorsObserver 9:31 a.m. April 25, 2014 - PR Newswire - PRF
The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio 7:02 a.m. April 23, 2014 - Marketwire
The Medicines Company Reports First Quarter 2014 Financial Results 7:02 a.m. April 23, 2014 - Marketwire
THE MEDICINES COMPANY 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against the Medicines Company - MDCO 10:01 p.m. April 18, 2014 - GlobeNewswire
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines 12:30 p.m. April 10, 2014 - PR Newswire - PRF